🇺🇸 ROIV — Roivant Sciences Ltd.

Salud Compra fuerte
← Volver

Precio actual

35,89 USD

Máx. histórico

41,81

54 días

Caída desde máximo

-14,16%

Rango 52 semanas

19,30 – 42,50

Variación hoy

-2,76%

Cierre anterior

36,91

Rango de hoy

35,81 – 37,29

Volumen hoy

5.699.508

Peor caída histórica

-79,22%

20/12/2021 → 12/05/2022

Recuperado en 1217 días

Volatilidad anualizada ⓘ

55,49%

Información
Nombre completo
Roivant Sciences Ltd.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
721
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
50,00 USD (puede no estar actualizado)
Primera cotización
08/12/2020
Precio actualizado
hace 17 horas
Sobre la empresa

Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several IgG-mediated autoimmune indications; mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease; neonatal fragment crystallizable receptor for the treatment of graves' disease, difficult-to-treat rheumatoid arthritis, sjögren's disease, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and cutaneous lupus erythematosus indications; batoclimab, a fully human monoclonal antibody for the treatment of thyroid eye disease; and brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis, cutaneous sarcoidosis, and other immune-mediated diseases. The company's lead program consists of mosliciguat, an inhaled sGC activator for the treatment of pulmonary hypertension associated with interstitial lung disease and other cardiopulmonary diseases. In addition, the company offers delivery platforms comprising a lipid nanoparticle (LNP) platform and a ligand conjugate platform. Roivant Sciences Ltd. was founded in 2014 and is based in London, United Kingdom.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
12/05/2026 29,01 29,80 28,80 29,39 +1,48% 3,45% 8.437.000
11/05/2026 28,61 29,51 28,60 28,96 +1,40% 3,18% 4.199.100
08/05/2026 28,36 28,90 28,17 28,56 +0,99% 2,56% 5.604.900
07/05/2026 28,84 28,86 27,87 28,28 -1,87% 3,43% 3.570.600
06/05/2026 28,47 28,86 28,42 28,82 +1,77% 1,53% 3.689.800
05/05/2026 28,64 29,00 28,06 28,32 -0,14% 3,28% 2.646.000
04/05/2026 28,48 28,48 27,52 28,36 +1,90% 3,37% 5.300.800
01/05/2026 28,79 28,93 27,83 27,83 -2,45% 3,84% 4.232.300
30/04/2026 27,93 28,71 27,89 28,53 +3,67% 2,94% 7.014.600
29/04/2026 27,74 27,94 27,45 27,52 -0,90% 1,75% 4.372.000
28/04/2026 28,02 28,58 27,72 27,77 -0,29% 3,08% 4.535.700
27/04/2026 27,46 28,37 27,30 27,85 +1,61% 3,88% 5.008.100
24/04/2026 28,24 28,32 27,06 27,41 -2,59% 4,46% 5.616.200
23/04/2026 29,25 29,41 27,92 28,14 -3,46% 5,08% 7.595.200
22/04/2026 29,53 29,64 29,00 29,15 -0,48% 2,17% 8.451.800
21/04/2026 29,03 29,36 28,67 29,29 +0,72% 2,38% 2.947.700
20/04/2026 29,74 29,88 28,94 29,08 -2,51% 3,16% 4.748.500
17/04/2026 29,54 30,18 29,00 29,83 +2,19% 3,99% 6.502.900
16/04/2026 29,65 29,65 28,98 29,19 -0,68% 2,28% 5.740.300
15/04/2026 29,32 29,49 28,86 29,39 +0,93% 2,17% 3.526.600
14/04/2026 29,02 29,69 28,96 29,12 +0,59% 2,52% 3.954.600
13/04/2026 28,21 29,19 28,21 28,95 +2,62% 3,47% 3.359.600
10/04/2026 28,48 28,54 27,95 28,21 -0,95% 2,07% 3.127.300
09/04/2026 27,98 28,78 27,93 28,48 +1,10% 3,06% 4.076.400
08/04/2026 28,45 28,76 28,15 28,17 +1,51% 2,16% 3.732.200
07/04/2026 27,91 28,02 27,40 27,75 -0,47% 2,22% 3.274.100
06/04/2026 28,06 28,45 27,70 27,88 -1,59% 2,69% 5.824.600
02/04/2026 26,95 28,55 26,62 28,33 +1,76% 7,16% 5.013.500
01/04/2026 28,13 28,39 27,72 27,84 +0,51% 2,38% 7.067.500
31/03/2026 26,75 28,17 26,64 27,70 +4,88% 5,72% 6.070.300